2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$15.00+$0.04 (+0.30%)
Price as of Oct 02, 2026 4:42 PM EDT- $801.8MMarket Cap
- 15.00%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$15.00+$0.04 (+0.30%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.95 | ||
Change | -$0.38 (-2.48%) | ||
Open | $15.24 | ||
High | $15.57 | ||
Low | $14.78 | ||
Previous Close | $15.33 | ||
Volume | 932,392 | ||
30-Day Average Volume | 1,147,451 | ||
1-Week Change | -4.90% | ||
1-Month Change | -21.11% | ||
1-Year Change | 15.00% | ||
3-Year Change | -48.39% | ||
5-Year Change | -99.77% | ||
Fundamentals | |||
Shares Outstanding | 53.6M | ||
Total Assets | $490.8M | ||
Market Cap | $801.8M | ||
Enterprise Value | $716.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$36.4M | ||
Free Cash Flow | -$20.0M | ||
EBIT | -$36.3M | ||
EBITDA | -$36.3M | ||
Net Working Capital | $386.8M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -18 | ||
PEG | -1 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue